Clinical Trials

Over the past several years, The John L. Trotter MS Center has participated in multiple clinical trials to evaluate the effectiveness of a variety of drugs and treatments for MS. Currently The John L. Trotter MS Center is the site of several different clinical trials involving patients with all forms of MS, including relapsing remitting, secondary progressive, and primary progressive. We are involved in trials to prevent the future worsening of MS, and to improve the quality of life of our patients.

Funding Sources

• The Barnes-Jewish Hospital MS Fund - contributions from patients, community members, foundations and corporations
• The National Multiple Sclerosis Society
• The National Institutes of Health

Links

National Multiple Sclerosis Society
National Multiple Sclerosis Society Gateway
Washington University School of Medicine

Clinical Trials Currently Enrolling Patients

Several clinical trials of treatments for MS patients are now recruiting MS patients. The trials we do change frequently, so it is best to inquire if you have questions. The following studies are still enrolling patients:

DECIDE Relapse Remitting Multiple Sclerosis

Dalfampridine (AMPYRA ®) after Optic Neuritis to Improve Visual Function in Multiple Sclerosis

Directional Diffusivity as a Window into the Pathology of MS

TERACLES Relapsing MS

ORATORIO - for Primary Progressive MS